Chemistry:CP-154,526

CP-154,526

Names
Preferred IUPAC name N-Butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[3,2-e]pyrimidin-4-amine
Identifiers
CAS Number	157286-86-7 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL9946 N
ChemSpider	4470592 N
IUPHAR/BPS	3495
PubChem CID	5311055
UNII	9A549FB00R Y
InChI InChI=1S/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3 N Key: FHQYJZCJRZHINA-UHFFFAOYSA-N N InChI=1/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3 Key: FHQYJZCJRZHINA-UHFFFAOYAW
SMILES CCCCN(CC)C1=NC(=NC2=C1C(=CN2C3=C(C=C(C=C3C)C)C)C)C
Properties
Chemical formula	C23H32N4
Molar mass	364.52698
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Tracking categories (test):

• SizeSet

CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.

CP-154,526 is under investigation for the potential treatment of alcoholism.

See also

• Antalarmin
• Pexacerfont
• Corticotropin releasing hormone antagonist

Further reading

• "The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review". CNS Drug Reviews 9 (1): 57–96. 2006. doi:10.1111/j.1527-3458.2003.tb00244.x. PMID 12595912. 
• "Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal". Molecular Pharmacology 77 (5): 864–73. May 2010. doi:10.1124/mol.109.062463. PMID 20159948. 
• "Pretreatment with CP-154526 blocks the modifying effects of alarm pheromone on components of sexual behavior in male, but not in female, rats". Chemical Senses 36 (7): 623–32. September 2011. doi:10.1093/chemse/bjr017. PMID 21502338. 

External links

• CP+154526 at the US National Library of Medicine Medical Subject Headings (MeSH)